2023 Q2 Form 10-Q Financial Statement

#000172138623000012 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $293.2M $241.7M
YoY Change -20.46% -23.55%
Cost Of Revenue $242.6M $197.8M
YoY Change -16.52% -21.23%
Gross Profit $50.66M $43.97M
YoY Change -35.12% -32.51%
Gross Profit Margin 17.28% 18.19%
Selling, General & Admin $44.31M $39.19M
YoY Change -13.44% -6.1%
% of Gross Profit 87.47% 89.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.139M $1.418M
YoY Change -20.9% -12.63%
% of Gross Profit 2.25% 3.22%
Operating Expenses $44.31M $39.19M
YoY Change -13.44% -6.1%
Operating Profit $6.347M $4.785M
YoY Change -76.4% -79.57%
Interest Expense $7.300M $4.600M
YoY Change -50.58% -28.39%
% of Operating Profit 115.01% 96.13%
Other Income/Expense, Net $1.159M $955.0K
YoY Change -158.62% 261.74%
Pretax Income $7.506M $5.740M
YoY Change -67.68% -68.34%
Income Tax $1.640M $1.617M
% Of Pretax Income 21.85% 28.17%
Net Earnings $4.947M $3.218M
YoY Change -66.88% -75.37%
Net Earnings / Revenue 1.69% 1.33%
Basic Earnings Per Share $0.12 $0.08
Diluted Earnings Per Share $0.12 $0.08
COMMON SHARES
Basic Shares Outstanding 40.05M shares 39.98M shares
Diluted Shares Outstanding 39.97M shares 40.12M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.19M $136.8M
YoY Change -25.58% 77.97%
Cash & Equivalents $74.19M $136.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.125B $1.081B
Prepaid Expenses
Receivables $4.800M
Other Receivables $0.00
Total Short-Term Assets $1.199B $1.218B
YoY Change -4.22% 0.39%
LONG-TERM ASSETS
Property, Plant & Equipment $13.80M
YoY Change 0.73%
Goodwill $68.64M $68.64M
YoY Change 0.0% -2.28%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.904M $2.760M
YoY Change -59.26% -82.63%
Total Long-Term Assets $207.3M $210.4M
YoY Change 46.04% 74.16%
TOTAL ASSETS
Total Short-Term Assets $1.199B $1.218B
Total Long-Term Assets $207.3M $210.4M
Total Assets $1.407B $1.428B
YoY Change 0.9% 7.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.90M $62.47M
YoY Change -14.69% -16.94%
Accrued Expenses $138.4M $135.2M
YoY Change 30.35% 37.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $212.2M $198.5M
YoY Change 9.38% 2.82%
LONG-TERM LIABILITIES
Long-Term Debt $482.7M $516.9M
YoY Change -9.71% 4.56%
Other Long-Term Liabilities $900.0K
YoY Change 200.0%
Total Long-Term Liabilities $482.7M $516.9M
YoY Change -9.76% 1.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $212.2M $198.5M
Total Long-Term Liabilities $482.7M $516.9M
Total Liabilities $749.3M $715.5M
YoY Change 2.79% 1.73%
SHAREHOLDERS EQUITY
Retained Earnings $166.5M $161.6M
YoY Change 47.62% 65.1%
Common Stock $490.7M $496.7M
YoY Change -1.09% -6.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $657.3M $658.3M
YoY Change
Total Liabilities & Shareholders Equity $1.407B $1.428B
YoY Change 0.9% 7.07%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $4.947M $3.218M
YoY Change -66.88% -75.37%
Depreciation, Depletion And Amortization $1.139M $1.418M
YoY Change -20.9% -12.63%
Cash From Operating Activities -$16.89M $5.477M
YoY Change 6.8% -117.04%
INVESTING ACTIVITIES
Capital Expenditures $2.008M $1.563M
YoY Change -217.63% -202.76%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$2.008M -$1.563M
YoY Change -1151.31% -99.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -43.70M $9.237M
YoY Change -213.66% -66.18%
NET CHANGE
Cash From Operating Activities -16.89M $5.477M
Cash From Investing Activities -2.008M -$1.563M
Cash From Financing Activities -43.70M $9.237M
Net Change In Cash -62.60M $13.15M
YoY Change -374.28% -104.94%
FREE CASH FLOW
Cash From Operating Activities -$16.89M $5.477M
Capital Expenditures $2.008M $1.563M
Free Cash Flow -$18.90M $3.914M
YoY Change 33.96% -112.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001721386
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38545
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Landsea Homes Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2196021
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1717 McKinney Avenue
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75202
CY2023Q1 dei City Area Code
CityAreaCode
949
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
345-8080
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40050088 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
136785000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123634000 usd
CY2023Q1 us-gaap Escrow Deposit
EscrowDeposit
2760000 usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
17101000 usd
CY2023Q1 us-gaap Inventory Real Estate
InventoryRealEstate
1080877000 usd
CY2022Q4 us-gaap Inventory Real Estate
InventoryRealEstate
1093369000 usd
CY2023Q1 us-gaap Due From Affiliates
DueFromAffiliates
4051000 usd
CY2022Q4 us-gaap Due From Affiliates
DueFromAffiliates
3744000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
68639000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
68639000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
134970000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
134009000 usd
CY2023Q1 us-gaap Assets
Assets
1428082000 usd
CY2022Q4 us-gaap Assets
Assets
1440496000 usd
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
62473000 usd
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
74445000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
135178000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
149426000 usd
CY2023Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
884000 usd
CY2022Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
884000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
516929000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
505422000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
715464000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
730177000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41245809 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40019283 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42110794 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40884268 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
496687000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
497598000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
161566000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
158348000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
658257000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
655950000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
54361000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
54369000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
712618000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
710319000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1428082000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1440496000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
241740000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
316227000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
197767000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
251073000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
43973000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
65154000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16408000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19148000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22780000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22586000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
39188000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
41734000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4785000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
23420000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
955000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
263000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 usd
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-5555000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5740000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18128000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1617000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5067000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4123000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
13061000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
905000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3218000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13065000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39997699 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45347369 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40116873 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45508556 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
710319000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
550000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-361000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
913000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4123000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
712618000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
621397000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
672000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
518000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3824000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13061000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
630480000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4123000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13061000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1418000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1623000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5555000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-361000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
518000 usd
CY2023Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
115000 usd
CY2022Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
90000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
580000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-270000 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-14341000 usd
CY2022Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
4270000 usd
CY2023Q1 lhi Increase Decrease In Real Estate Inventories
IncreaseDecreaseInRealEstateInventories
-13184000 usd
CY2022Q1 lhi Increase Decrease In Real Estate Inventories
IncreaseDecreaseInRealEstateInventories
32191000 usd
CY2023Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
307000 usd
CY2022Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
568000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2232000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16151000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11972000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4851000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13412000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5313000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5477000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32141000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1563000 usd
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1521000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 usd
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
283000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
260330000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1563000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-261568000 usd
CY2023Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
175000000 usd
CY2022Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
69612000 usd
CY2023Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
164300000 usd
CY2022Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
37715000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
550000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
672000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3824000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
913000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
87000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9237000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27314000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13151000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-266395000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123634000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343253000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136785000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76858000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 segment
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates—The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.
CY2023Q1 lhi Inventory Real Estate Deposits And Pre Acquisition Costs
InventoryRealEstateDepositsAndPreAcquisitionCosts
99458000 usd
CY2022Q4 lhi Inventory Real Estate Deposits And Pre Acquisition Costs
InventoryRealEstateDepositsAndPreAcquisitionCosts
101395000 usd
CY2023Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
185049000 usd
CY2022Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
191047000 usd
CY2023Q1 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
769798000 usd
CY2022Q4 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
779352000 usd
CY2023Q1 lhi Inventory Real Estate Model Homes
InventoryRealEstateModelHomes
26572000 usd
CY2022Q4 lhi Inventory Real Estate Model Homes
InventoryRealEstateModelHomes
21575000 usd
CY2023Q1 us-gaap Inventory Real Estate
InventoryRealEstate
1080877000 usd
CY2022Q4 us-gaap Inventory Real Estate
InventoryRealEstate
1093369000 usd
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
11900000 usd
CY2022Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
7300000 usd
CY2023Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4600000 usd
CY2022Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6400000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5900000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7200000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10500000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11600000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8071000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8878000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
516929000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
505422000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
46657000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
15692000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
911000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1601000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1338000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
536000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
46230000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
16757000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.046
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13700000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14700000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15600000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16400000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3017000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3357000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2418000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2140000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1915000 usd
CY2023Q1 lhi Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4183000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17030000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2376000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14654000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.282
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.280
CY2023Q1 lhi Number Of Geographic Regions
NumberOfGeographicRegions
5 segment
CY2023Q1 lhi Number Of Geographic Regions
NumberOfGeographicRegions
5 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
241740000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
316227000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5740000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18128000 usd
CY2023Q1 us-gaap Assets
Assets
1428082000 usd
CY2022Q4 us-gaap Assets
Assets
1440496000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41200000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 lhi Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
10000000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15525000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3218000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13065000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
0 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
289000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3218000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12776000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
39997699 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
46347369 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
0 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
1000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39997699 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45347369 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
119174 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
161187 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40116873 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45508556 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7100000 shares
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 lhi Change In Right Of Use Assets For New Modified Or Terminated Operating Leases
ChangeInRightOfUseAssetsForNewModifiedOrTerminatedOperatingLeases
-837000 usd
CY2022Q1 lhi Change In Right Of Use Assets For New Modified Or Terminated Operating Leases
ChangeInRightOfUseAssetsForNewModifiedOrTerminatedOperatingLeases
385000 usd

Files In Submission

Name View Source Status
0001721386-23-000012-index-headers.html Edgar Link pending
0001721386-23-000012-index.html Edgar Link pending
0001721386-23-000012.txt Edgar Link pending
0001721386-23-000012-xbrl.zip Edgar Link pending
exhibit311-certificationx2.htm Edgar Link pending
exhibit312-certificationx2.htm Edgar Link pending
exhibit321-certificationx2.htm Edgar Link pending
exhibit322-certificationx2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lhi-20230331.htm Edgar Link pending
lhi-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
lhi-20230331_cal.xml Edgar Link unprocessable
lhi-20230331_pre.xml Edgar Link unprocessable
lhi-20230331_lab.xml Edgar Link unprocessable
lhi-20230331_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lhi-20230331_def.xml Edgar Link unprocessable